894 related articles for article (PubMed ID: 10804039)
1. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
2. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
3. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
Bodsworth NJ; Crooks RJ; Borelli S; Vejlsgaard G; Paavonen J; Worm AM; Uexkull N; Esmann J; Strand A; Ingamells AJ; Gibb A
Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092
[TBL] [Abstract][Full Text] [Related]
4. Valaciclovir: a review of its use in the management of herpes zoster.
Ormrod D; Goa K
Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
[TBL] [Abstract][Full Text] [Related]
5. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
[TBL] [Abstract][Full Text] [Related]
6. Valaciclovir: development, clinical utility and potential.
Patel R
Expert Opin Investig Drugs; 1997 Feb; 6(2):173-89. PubMed ID: 15989601
[TBL] [Abstract][Full Text] [Related]
7. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
[TBL] [Abstract][Full Text] [Related]
8. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.
Conant MA; Schacker TW; Murphy RL; Gold J; Crutchfield LT; Crooks RJ;
Int J STD AIDS; 2002 Jan; 13(1):12-21. PubMed ID: 11802924
[TBL] [Abstract][Full Text] [Related]
9. [Valaciclovir].
Lebrun-Vignes B
Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):708-15. PubMed ID: 12124513
[TBL] [Abstract][Full Text] [Related]
10. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
11. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R
Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
[TBL] [Abstract][Full Text] [Related]
12. Valaciclovir: new indications. In genital herpes: simpler administration.
Prescrire Int; 1999 Feb; 8(39):8-9. PubMed ID: 10557565
[TBL] [Abstract][Full Text] [Related]
13. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
[TBL] [Abstract][Full Text] [Related]
14. Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.
Pinder M; Wright A
Int J STD AIDS; 2015 Nov; 26(13):971-3. PubMed ID: 25505043
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
16. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
Simpson D; Lyseng-Williamson KA
Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
Feinberg JE; Hurwitz S; Cooper D; Sattler FR; MacGregor RR; Powderly W; Holland GN; Griffiths PD; Pollard RB; Youle M; Gill MJ; Holland FJ; Power ME; Owens S; Coakley D; Fry J; Jacobson MA
J Infect Dis; 1998 Jan; 177(1):48-56. PubMed ID: 9419169
[TBL] [Abstract][Full Text] [Related]
18. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
19. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
